References
- Schipper HM. Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim. J Neural Transm 2010;118:381–7.
- Levenson CW, Tassabehji NM. Iron and ageing: an introduction to iron regulatory mechanisms. Ageing Res Rev 2004;3:251–63.
- Altamura S, Muckenthaler MU. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 2009;16:879–95.
- Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, Liu B. Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci 2009;29:1335–47.
- Seabrook GR, Rosahl TW. Transgenic animals relevant to Alzheimer's disease. Neuropharmacology 1999;38:1–17.
- Jolas T, Zhang XS, Zhang Q, Wong G, Del Vecchio R, Gold L. Long-term potentiation is increased in the CA1 area of the hippocampus of APP(swe/ind) CRND8 mice. Neurobiol Dis 2002;11:394–409.
- Strazielle C, Sturchler-Pierrat C, Staufenbiel M, Lalonde R. Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation. Neuroscience 2003;118:1151–63.
- Fitzjohn SM, Doherty AJ, Collingridge GL. The use of the hippocampal slice preparation in the study of Alzheimer's disease. Eur J Pharmacol 2008;585:50–9.
- Kawabata T, Awai M, Kohno M. Generation of active oxygen species by iron nitrilotriacetate (Fe-NTA). Acta Med Okayama 1986;40:163–73.
- Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987;47:1867–9.
- Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979;95:663–73.
- Nakatsuka I, Maeda S, Andoh T, Hayashi Y, Mizuno R, Higuchi H. Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate. Redox Rep 2009;14:109–14.
- Dolev I, Michaelson DM. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci USA 2004;101:13909–14.
- Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 1966;13:655–69.
- Bostanci MO, Bas O, Bagirici F. Alpha-tocopherol decreases iron-induced hippocampal and nigral neuron loss. Cell Mol Neurobiol 2010;30:389–94.
- Liu R, Liu W, Doctrow SR, Baudry M. Iron toxicity in organotypic cultures of hippocampal slices: role of reactive oxygen species. J Neurochem 2003;85:492–502.
- White P, Hiley CR, Goodhardt MJ, Carrasco LH, Keet JP, Williams IE. Neocortical cholinergic neurons in elderly people. Lancet 1977;1:668–71.
- Volpicelli LA, Levey AI. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 2004;145:59–66.
- West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769–72.
- Hayakawa N, Yokoyama H, Kato H, Araki T. Age-related alterations of oxidative stress markers in the mouse hippocampal CA1 sector. Exp Mol Pathol 2008;85:135–40.
- Haces ML, Montiel T, Massieu L. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience 2010;165:28–38.
- Wang X, Zaidi A, Pal R, Garrett AS, Braceras R, Chen XW. Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress. BMC Neurosci 2009;10:12.
- Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866–8.
- Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000;74:270–9.